FDA Approves ELTROMBOPAG — Dr. Reddy's Laboratories Inc.,
Dr. Reddy’s Laboratories Inc. announced the FDA approval of its oral Eltrombopag Olamine (ANDA219121), which is slated for March 16, 2026, and positions the company to capture mark…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Dr. Reddy’s Laboratories Inc. announced the FDA approval of its oral Eltrombopag Olamine (ANDA219121), which is slated for March 16, 2026, and positions the company to capture mark…
# FDA Approves Generic Citalopram for Aurobindo Pharma Aurobindo Pharma Limited has received FDA approval for its generic citalopram hydrobromide oral formulation (ANDA219985), en…
# FDA Approves Generic Drug Application for Hetero Labs Hetero Labs Ltd III received FDA approval for an abbreviated new drug application (ANDA218264) on March 12, 2026, positioni…
# FDA Approves Generic Liraglutide from Biocon Pharma Inc. Biocon Pharma Inc. has received FDA approval for its generic formulation of liraglutide (ANDA215245), a widely-prescribe…
# FDA Approves Zydus Lifesciences' Generic Cevimeline Hydrochloride Zydus Lifesciences Limited has received FDA approval for its generic cevimeline hydrochloride oral formulation,…
# FDA Approves DIFGEN Pharms Generic Drug Application DIFGEN Pharms has received FDA approval for its abbreviated new drug application (ANDA 219997), potentially expanding the com…
The FDA has granted approval to YICHANG HUMANWELL for a new Abbreviated New Drug Application, extending the company’s commercial footprint in the generic sector and supporting ongo…
# FDA Approves E5 Pharma ANDA Application E5 Pharma has received FDA approval for ANDA216808, marking a significant expansion of the company's generic drug portfolio and positioni…
# FDA Approves KNACK's Generic Drug Application KNACK has received FDA approval for its abbreviated new drug application (ANDA 218675), positioning the company to capture market s…
# FDA Approves ANDA for Steranco Healthcare Steranco Healthcare has received FDA approval for an abbreviated new drug application (ANDA220281), positioning the company to expand i…
CONTRACT PHARMACAL today announced that the FDA has granted approval for its ANDA #219603, a milestone likely to boost the company's generic revenue streams as it prepares for the …
# FDA Approves Solco Healthcare's Generic Gabapentin The FDA has approved Solco Healthcare US, LLC's abbreviated new drug application for generic gabapentin oral formulation, expa…
# FDA Approves Aurobindo Pharma Generic Drug Application The U.S. Food and Drug Administration has approved Aurobindo Pharma Ltd.'s abbreviated new drug application (ANDA218459) a…
# FDA Approves Mylan ANDA Application Mylan received FDA approval for ANDA218851 on March 5, 2026, expanding the company's generic drug portfolio and positioning it to capture add…
# FDA Approves Glenmark Pharmaceuticals' Generic Olanzapine Injection, Expanding Long-Acting Antipsychotic Market The FDA has approved Glenmark Pharmaceuticals Inc.'s abbreviated …
# FDA Approves Advagen Pharma's Generic Children's Ibuprofen Advagen Pharma Ltd. received FDA approval for its generic Children's Ibuprofen oral formulation (ANDA220239) on March …
# FDA Approves Zydus Pharmaceuticals' Generic Calcitonin Salmon Injection The FDA has approved Zydus Pharmaceuticals USA Inc.'s generic calcitonin salmon intramuscular injection (…
# FDA Approves ASPIRO's Generic Drug Application ASPIRO has received FDA approval for its abbreviated new drug application (ANDA 220124), expanding the company's generic pharmaceu…
# FDA Approves Generic Moxifloxacin ANDA from Macleods Pharmaceuticals Macleods Pharmaceuticals Limited has received FDA approval for its generic moxifloxacin hydrochloride oral f…
# FDA Approves Epic Pharma's Generic Drug Application Epic Pharma LLC has received FDA approval for an abbreviated new drug application (ANDA 219556), marking another addition to …